ChartRow logo
Share this page
KRYS
$316.58-4.07%
as of close, Oct 16, 2026
☾ AH $316.58 -4.07%
PeersMRNALLYMDTUNHJNJTMO

Krystal Biotech Inc. trailing returns

How Krystal Biotech Inc. (KRYS) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-4.1%+0.0%-4.1%—
5 days-4.5%+0.0%-4.5%-4.7%Oct 16
1 month-6.0%+0.0%-6.0%-9.8%Oct 16
YTD+28.4%+0.0%+28.4%-17.3%Aug 3
1 year+68.1%+0.0%+68.1%-17.3%Aug 2026
5 years+45.4%+0.0%+45.4%+549.8%-44.5%May 2022
Since inception (2017)+45.4%+0.0%+45.4%+2875.4%-53.4%Nov 2021

Growth of KRYS#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+45.4%/year · +549.8%
  • Since inception (2017)+45.4%/year · +2875.4%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in KRYS's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Krystal Biotech Inc.'s return since inception?
Since 2017, Krystal Biotech Inc. (KRYS) has compounded at about +45.4% a year — +2875.4% in total.

More on Krystal Biotech Inc.